Psychopathological Correlates of Reduced Dopamine Receptor Sensitivity in Depression, Schizophrenia, and Opiate and Alcohol Dependence12
The DOI matches its Crossref record.
Abstract
A dysfunction of central dopaminergic neurotransmission has been found in various neuropsychiatric diseases, and may be associated with a common psychopathological correlate. One hypothesis suggests that dopaminergic stimulation of the brain reward system reinforces behavior because it is experienced as pleasurable, and that dopaminergic dysfunction leads to anhedonia, the inability to experience pleasure. An alternative hypothesis assumes that dopaminergic stimulation does not promote pleasure or "liking" of a reward but rather mediates "wanting" of a reward, and suggests that dopaminergic dysfunction is associated with a failure to be motivated by stimuli that indicate reward. We measured negative symptoms, psychomotor slowing and dopamine receptor sensitivity in twelve drug-free patients with major depression, seventeen alcohol-dependent and sixteen opiate-dependent patients, ten schizophrenics with neuroleptic medication, and ten healthy controls. The sensitivity of central dopamine receptors was assessed with the growth hormone response to apomorphine application. Psychomotor slowing was measured in a reaction-time test and anhedonia and other negative symptoms were assessed with self-rating scales and the Scale for the Assessment of Negative Symptoms. Patients with major depression, alcohol dependence and neuroleptic medication displayed a reduced sensitivity of central dopamine receptors compared to control subjects. Anhedonia was not a common correlate of dopamine receptor dysfunction. Instead, affective flattening was associated with both dopamine receptor sensitivity and psychomotor slowing. Our findings thus do not support the anhedonia hypothesis of central dopaminergic dysfunction. Rather, affective flattening may result from the lack of an emotional response towards reward-indicating stimuli. These findings indicate that patients with dopaminergic dysfunction are not unable to experience pleasure, but may fail to be motivated by environmental stimuli to seek reward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
“Considerable evidence from both animal and human studies indicates that mesolimbic and striatal DA is involved in these pathological aspects of motivation (Schmidt et al., 2001; Volkow et al., 2001; Salamone et al., 2006, 2007, 2012; Miller, 2009; Treadway and Zald, 2011).”
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits
Salamone, J. D., Correa, M., Farrar, A., & Mingote, S. M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0668-9 · Cited by 1,000
Dysfunction of ventral striatal reward prediction in schizophrenia
Juckel, G., Schlagenhauf, F., Koslowski, M., Wüstenberg, T., Villringer, A., Knutson, B., Wrase, J., & Heinz, A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.051 · Cited by 578
Self-citationNutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366
“There are data to suggest that symptoms of ‘decreased positive affect’ are associated with dysregulation of DA and NE neurotransmission (Gold and Chrousos, 1998; Schmidt et al., 2001).”
BackgroundSalamone, J. D., Yohn, S. E., López-Cruz, L., San Miguel, N., & Correa, M. (2016) · Brain · doi:10.1093/brain/aww050 · Cited by 350
Heinz, A. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00628-4 · Cited by 270
Self-citationBrain dopamine is associated with eating behaviors in humans
Volkow, N. D., Wang, G., Maynard, L., Jayne, M., Fowler, J. S., Zhu, W., Logan, J., Gatley, S. J., Ding, Y., Wong, C., et al. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10118 · Cited by 235
Blum, K., Gardner, E., Oscar-Berman, M., & Gold, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919110 · Cited by 218
“[49] did not support the anhedonia hypothesis of central dopaminergic dysfunction as proposed other by investigators [50-52].”
ResultGarfield, J. B. B., Lubman, D. I., & Yücel, M. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413508455 · Cited by 213
“Alcoholdependent patients showed significantly elevated anhedonia 6–36 h after their last drink, as indexed by the PAS and SANSanh, relative to controls (Schmidt et al., 2001).”
BackgroundResultInfluentialEmotional blunting with antidepressant treatments: A survey among depressed patients
Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.048 · Cited by 202
Abler, B., Erk, S., & Walter, H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0690-y · Cited by 118
“Furthermore, reduced sensitivity of dopamine receptors in the course of neuroleptic treatment has been associated with increased negative symptoms that may be related to a dysfunctional response to rewarding stimuli in patients (Schmidt et al. 2001).”
BackgroundProgress in understanding mood disorders: optogenetic dissection of neural circuits
Lammel, S., Tye, K. M., & Warden, M. R. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12049 · Cited by 98
Brain PET Imaging in Obesity and Food Addiction: Current Evidence and Hypothesis
Iozzo, P., Guiducci, L., Guzzardi, M. A., & Pagotto, U. (2012) · Obesity Facts · doi:10.1159/000338328 · Cited by 27
Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0193-2 · Cited by 18
Metadata
- Authors
- Schmidt, K., Nolte-Zenker, B., Patzer, J., Bauer, M., Schmidt, L. G., & Heinz, A.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001-03
- Volume
- 34
- Issue
- 2
- Pages
- 66-72
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2050552296
- Cited by
- 96
- References
- 0
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.